WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Pulsed laser system for the surgical removal of tissue    
United States Patent5312396   
Link to this pagehttp://www.wikipatents.com/5312396.html
Inventor(s)Feld; Michael S. (Waban, MA); Itzkan; Irving (Boston, MA); Albagli; Douglas (Cambridge, MA); Izatt; Joseph A. (Cambridge, MA); Hayes; Gary B. (Leominster, MA); Rava; Richard (Waltham, MA)
AbstractRemoval of body tissue with a long pulsed lasers is achieved such that sufficient energy to remove tissue is transmitted to the desired body without damaging an optical fiber transmitting the laser radiation. Pairs of pulses having the same or different wavelengths are coupled to more effectively remove tissue from the surgical site.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5312396
Pulsed laser system for the surgical removal of tissue - US Patent 5312396 Drawing
Pulsed laser system for the surgical removal of tissue
Inventor     Feld; Michael S. (Waban, MA); Itzkan; Irving (Boston, MA); Albagli; Douglas (Cambridge, MA); Izatt; Joseph A. (Cambridge, MA); Hayes; Gary B. (Leominster, MA); Rava; Richard (Waltham, MA)
Owner/Assignee     Massachusetts Institute of Technology (Cambridge, MA)
Patent assignment
All assignments
Publication Date     May 17, 1994
Application Number     07/644,202
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     January 22, 1991
US Classification     606/11 606/2 606/3 606/7 606/10 606/13 606/17 607/88 607/89 607/94
Int'l Classification     A61B 017/36 A61N 003/00
Examiner     Green; Randall L.
Assistant Examiner     Zuttarelli; P.
Attorney/Law Firm     Hamilton, Brook, Smith & Reynolds
Address
Parent Case     Submitted herewith for filing is a Continuation-in-Part application of prior Ser. No. 07/578,645 filed Sept. 6, 1990.
Priority Data    
USPTO Field of Search     606/2 606/3 606/2 606/3 606/2 606/3 606/128 128/395 128/396 128/397 607/88 607/89 607/90 607/92 607/93 607/94
Patent Tags     pulsed laser surgical removal tissue
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3136310



[0 after 0 votes]
5139494
Freiberg
606/3
Aug,1992

[0 after 0 votes]
5009658
Damgaard-Iversen
606/2.5
Apr,1991

[0 after 0 votes]
4913142
Kittrell
606/7
Apr,1990

[0 after 0 votes]
4887600
Watson
606/2.5
Dec,1989

[0 after 0 votes]
4862886
Clarke
606/7
Sep,1989

[0 after 0 votes]
4848336
Fox
606/7
Jul,1989

[0 after 0 votes]
4830460
Goldenberg
385/118
May,1989

[0 after 0 votes]
4791927
Menger
606/3
Dec,1988

[0 after 0 votes]
4682594
Mok
606/7
Jul,1987

[0 after 0 votes]
4681104
Edelman
606/7
Jul,1987

[0 after 0 votes]
4672969
Dew
607/89
Jun,1987

[0 after 0 votes]
4641912
Goldenberg
385/43
Feb,1987

[0 after 0 votes]
4601037
McDonald
372/25
Jul,1986

[0 after 0 votes]
4587972
Morantte, Jr.
600/439
May,1986

[0 after 0 votes]
4564011
Goldman
606/9
Jan,1986

[0 after 0 votes]
4470407
Hussein
600/108
Sep,1984

[0 after 0 votes]
4445892
Hussein
604/101.05
May,1984

[0 after 0 votes]
4418688
Loeb
600/108
Dec,1983

[0 after 0 votes]
4207874
Choy
600/108
Jun,1980

[0 after 0 votes]
4072147
Hett
600/181
Feb,1978

[0 after 0 votes]
3858577
Bass
600/108
Jan,1975

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


We claim:

1. A method of removing material from a surgical site comprising:

irradiating a portion of material with a first pulse of light having a first wavelength and pulse duration to prepare the material without creating a plasma and without removal of material by the first pulse of light; and

irradiating the portion with a second pulse of light having a second wavelength longer than the first wavelength and within a selected period following the first pulse to remove the portion of material from the surgical site, a depth of propagation of the second pulse within the material being substantially reduced by the first pulse during the selected period.

2. The method of removing material from a vascular lumen of claim 1 wherein the second pulse irradiates cancerous material at the site within a selected period following the first pulse, the period having a duration of less than 1 millisecond.

3. The method of removing material of claim 1 wherein the first wavelength is a selected harmonic of an output beam from a laser.

4. The method of removing material of claim 3 wherein the second wavelength is a further selected harmonic of the output beam from the laser.

5. The method of removing material of claim 1 wherein the first wavelength is in a range between 300 nm and 400 nm.

6. The method of removing material of claim 1 wherein the second wavelength is in a range between 400 nm and 3000 nm.

7. The method of removing material of claim 1 wherein the irradiating steps comprise irradiating the material including atherosclerotic plaque located within an arterial lumen of a patient with a Nd:YAG laser.

8. A laser angiosurgery system for removing material including plaque from a site within an arterial lumen of a patient comprising:

a fiber-optic catheter having a cross-sectional area to permit insertion of the catheter into an arterial lumen of a patient;

a laser system providing first and second wavelengths of light that can be coupled to a proximal end of the catheter to deliver laser radiation to a site in the lumen and further comprising:

a control system connected to the laser system such that the laser system generates a first pulse of radiation having the first wavelength and a second pulse of radiation having the second wavelength, the first and second pulses being transmitted through the catheter that delivers the first and second pulses to a region of material including plaque at the site within a selected period of time such that the first pulse irradiates the material without creation of a plasma to alter an optical absorption characteristic of the material upon delivery of the second pulse to the material, the first and second pulses acting in combination to deliver sufficient energy to the region to remove material including plaque at the site in the lumen.

9. The system for removing material from a site of claim 8 wherein the laser system comprises a Nd:YAG laser.

10. The system for removing material from a site of claim 8 wherein the first wavelength is in the range between 300 nm and 400 nm.

11. The system for removing material from a site of claim 8 wherein the second wavelength is in the range between 400 nm and 3000 nm.

12. The system for removing material from a site of claim 8 wherein the second pulse irradiates the tissue within a selected period following the first pulse, the period having a duration of less than 1 millisecond.

13. The system for removing material from a site of claim 8 wherein the first wavelength is a selected harmonic of an output beam from a laser and the second wavelength is a further selected harmonic of the output beam from the laser.

14. The system for removing material from a site of claim 8 wherein the first wavelength has an ultraviolet wavelength and the second wavelength has a visible wavelength.

15. The system for removing material from a site of claim 8 wherein the first wavelength has an ultraviolet wavelength and the second wavelength has an infrared wavelength.

16. A system for removing material from a site comprising:

a first laser providing a first wavelength of radiation;

a second laser providing a second wavelength of radiation that is longer than the first wavelength;

a control system connected to the first laser and the second laser to generate a first pulse of radiation having the first wavelength and a second pulse having the second wavelength, the first and second pulses being received by an optical system that delivers the first and second pulses to a region of the material within a selected period of time such that the first pulse irradiates the material without creating a plasma and without removing material from the site to alter an optical absorption characteristic of the material upon delivery of the second pulse to the material which removes material from the site.

17. The system for removing material from a site of claim 16 wherein the first or second laser comprises a Nd:YAG laser.

18. The system for removing material from a site of claim 16 wherein the first wavelength is in the range between 300 nm and 400 nm and the second wavelength is in the range between 400 nm and 3000 nm.

19. The system for removing material from a site of claim 16 wherein the second pulse irradiates the tissue within the selected period following the first pulse, the period having a duration of less than 1 millisecond.

20. The system for removing material from a site of claim 16 wherein the second pulse has an energy density sufficient to remove atherosclerotic plaque from the site.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

Surgical methods are being developed to ablate tissue by inserting an optical fiber catheter into a body lumen and passing laser light through the fiber optics onto the surgical site. Laser catheters employing optical fibers to deliver laser radiation to ablate tissue are coupled to pulsed Xe:Cl excimer or other suitably powered lasers. However, there are many problems associated with using excimer lasers with a wavelength of 308 nm, for example. Noxious gases used with excimer lasers must be vented. The laser is extremely large and bulky and generates an excessive amount of electrical noise that may affect other hospital equipment. As a consequence, excimer lasers require heavy shielding. Moreover, the laser beam quality is so poor that optical processing of the beam is difficult. Also, the excimer laser generates light in the UV-B range resulting in the potential for mutagenicity of the irradiated tissue. The use of such a system at a wavelength of 308 nm is known to cause cataracts. In view of the dangers associated with excimer lasers and other problems associated with other existing medical lasers, a need exists for the development of a surgical laser system more suitable for a hospital environment, that will provide a radiation source suitable for tissue ablation and provide a more convenient and reliable laser source for a variety of medical applications.

SUMMARY OF THE INVENTION

To avoid the problems associated with excimer lasers, we have chosen a solid state ND:YAG laser, frequency tripled to 355 nm, to ablate tissue. The pulses produced by currently available lasers such as ND:YAG, doubled alexandrite, or Ti:sapphire are short (approximately 100 ns or less) and at the energies required for ablation the use of optical fiber waveguides to deliver the radiation to tissue can result in damage to the optical fibers. Other laser host materials can be used, such as YALO, or yttrium aluminate. Also, other types of solid state lasers such as holmium doped lasers can be used. By providing a laser pulse of sufficient duration and energy from a solid state laser, tissue can be ablated without damaging the optical fiber used to deliver radiation to the surgical site. The laser output may be a single pulse or a plurality of pulses with a fluence, or energy/cm.sup.2, sufficient to remove tissue. Moreover, the laser wavelength is preferably in the range of 320 to 400 nm.

The laser surgery techniques can be extended to all tissues of the body. For example, skin lesions can be excised by direct application of a laser beam without transmission through optical fibers. Similarly, a solid state laser beam can be used for the removal of cancerous or precancerous material during surgery. Also, a catheter can be used to apply the solid state laser beam to calcified material or soft tissue within a body lumen. Laser revascularization of coronary arteries utilizing solid state lasers can thus remove calcified plaque. Spectroscopic diagnostics are utilized to determine what tissue is to be removed. Moreover, in vitro applications are useful for biopsy and autopsy purposes.

In the preferred embodiment, the short pulse output of the solid state YAG laser is transmitted to an optical "extender" for "stretching" the initial pulse into a train of a selected number of pulses, each delayed by a given time interval, the train of pulses resulting in the "filling" in of overlapped pulses. Thus, pulses having a desired waveform can be lengthened by overlapping several pulses. When the interpulse delay is less than the initial, or seed pulse duration, the train of pulses overlap into a single pulse. When a plurality of initial, or seed pulses are received by the filler/multiplexer, the separation between the resulting output pulses are such that the pulse trains from the respective initial pulses do not overlap.

The optical extender utilizes beam splitters and mirrors to produce the desired pulse trains. Similarly, a pulse filler/multiplexer utilizes a selected number of different optical delay paths which are combined by beam splitters to produce the desired number of outputs. The positions of the pulse extender and pulse filler can be reversed to optimize particular operating conditions. Pulse duration is set such that tissue is removed without damaging the transmitting optical fibers.

In another preferred embodiment a solid state laser per se can be constructed to produce pulses having the desired duration, power and shape to remove tissue. For example, a slow Q switched, mode locked laser can be used to provide such a pulse. Also, two or more lasers can be used to produce pulses with the desired time separation between pulses from the respective lasers. Thus, with our invention, a system is provided for the precise laser machining of all human tissues.

A further embodiment of the present invention relates to the use of two or more colors or wavelengths of light to further increase the effectiveness of the tissue ablation process. In this procedure the removal of a selected region of tissue is initiated using a pulse of light of one wavelength and then completing the removal of the selected region by irradiating the same region with a second pulse of light of another wavelength.

The first pulse can produce transient or non-transient changes in the tissue. In the case of transient changes, the second pulse is delivered to the tissue within a period of time that is short enough to work in combination with the first pulse. It is by coupling the effects of two pulses of different wavelengths that has resulted in a substantial increase in ablation effectiveness.

The first pulse operates to prepare the tissue by thermal, photochemical, vibrational or electronic excitation mechanisms that either alone, or in combination, alter the absorption and/or scattering characteristics of the tissue relative to the second pulse of different wavelength. The precise mechanism by which the absorption and/or scattering characteristics of the tissue is altered is dependent upon the type of tissue, the pulse duration, temporal separation of pulse pairs, the wavelengths of the pulses and the energy delivered by each pulse to the tissue. Note that the first pulse can also produce some permanent non-reversible change that can be used to prepare the tissue. In this embodiment the temporal separation of the pulses is not as critical for effective two color ablation. Generally, this type of tissue preparation is photochemical in nature.

In one embodiment a ND:YAG laser produces single pulses each of which is divided into a first subpulse that is tripled (to 355 nm, for example) and delivered to arterial tissue, and a second pulse, at the fundamental frequency (1066 nm), that is delivered to the tissue through an optical delay to provide the desired pulse separation, within one microsecond of the first pulse. The first 355 nm pulse alters the propagation of light through the irradiated tissue such that the second pulse is more fully absorbed by the tissue and results in the removal of the desired amount of tissue. For the purposes of the present application, it is the use of the first pulse to increase the rate of attenuation of the second pulse as it propagates through the tissue that is critical to effective ablation.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates the output pulse of a typical solid state laser relative to a preferred rectangular pulse.

FIG. 2 illustrates the rate of tissue ablation and the probability of optical fiber survival as a function of pulse separation.

FIG. 3 is a sectional view of a laser catheter embodiment disposed in the bend of an artery and illustrating the device in operation.

FIG. 4 is a block diagram of a system in accordance with the invention for removal of unwanted deposits in an artery.

FIG. 5 shows an optical extender for converting a short pulse into a train of 3 to 4 pulses.

FIG. 6 illustrates another optical extender which can transform a single short pulse into a train of several pulses delayed by a given time interval.

FIG. 7 shows a pulse broadening multiplexer which generates a plurality of overlapping pulses.

FIG. 7a shows the pulse outputs generated by the multiplexer.

FIG. 8(a)-(e) and 9(a)-(c) show various laser pulse outputs which are effective for removing tissue.

FIG. 10 shows a further embodiment of the pulse broadening multiplexer.

FIG. 11 illustrates a further embodiment of the laser subsystem to be employed in a sequenced pulse ablation procedure.

FIG. 12 illustrates the fluence thresholds that are necessary to provide ablation using various lasers.

FIG. 13 illustrates the particular wavelengths and energy levels of a particular two color ablation process.

FIG. 14 is a three-dimensional graphical representation illustrating crater depth in a tissue sample as a function of fluence of the two colors or wavelengths being employed.

FIG. 15 is a graphical illustration of crater depth in bone tissue versus pulse separation of sequenced pulse ablation using one and two wavelengths.

FIG. 16 is a graphical illustration of crater depth in bone tissue for selected pulse pairs.

DETAILED DESCRIPTION OF THE INVENTION

FIG. 1 illustrates the typical pulsed output 12 of a solid state laser. The rectangular pulse 14 represents an optimal pulse configuration that can be approximated by the methods described below. The amplitude of pulse 14 is much less than the peak amplitude of output 12. Also, the peak height of pulse 14 is small relative to its time length duration. However, the areas under the respective curves 12 and 14 are comparable. When the duration of pulse 14 with the necessary fluence is sufficiently long and has the necessary energy density it provides an improved pulse configuration for the ablation of tissue. A wavelength of 355 nm is advantageous in that it produces a desirably small penetration depth in body tissue. Thus, by controlling the penetration depth with the appropriate selection of wavelength, damage to underlying healthy tissue is reduced. Moreover, ND:YAG lasers can be used safely in hospitals, have good beam quality, and operate at non-mutagenic wavelengths. However, Nd:YAG lasers generally produce only frequency tripled short pulses having the necessary ablation energy (of a duration approximately 10 ns) efficiently.

Solid state lasers can produce long duration pulses by using long, high-Q cavities or by appropriate Q switching techniques. However, it is difficult to produce a long duration pulse with a frequency tripled solid state laser. Since, it is often desirable to use optical fiber waveguides to deliver radiation to a surgical site, particularly at locations accessible through body lumens, long duration pulses are used with sufficient energy to remove tissue and which can pass through without damaging the bulk material or surface of that fiber.

FIG. 2 illustrates the two conditions which must be met to transmit a satisfactory output pulse. First, sufficient energy must be transmitted to the body area to remove tissue. Second, the energy must be below the threshold of damage for the optical fiber. The respective materials were tested using two short pulses (7.5 ns) at a wavelength of 355 nm laser light of equal energy. The pulses were delayed by an amount varying from 1 nanosecond to 1 second.

The effect of various pulse delays on body tissue is shown by the dotted line in FIG. 2. The tissue effectively "remembers" that it has been irradiated for times in excess of several microseconds i.e., energy deposited in tissue can be stored for several microseconds and the energy needed to reach the ablation threshold is cumulative over this period. It has been found that the rate of ablation or crater depth is a maximum under these conditions for a pulse separation less than 100 nsec and decreases steadily to zero at 100 msec separation. However, effective ablation can generally occur at a pulse separation of less than 1 msec.

The selection of an appropriate combination of laser wavelength, pulse energy and pulse duration is critical to properly remove body tissue. The proper choice of laser pulse parameters is especially important for the removal of calcified plaque. It has been found that the most efficient removal of "hard" biological tissue occurs when wavelengths below 400 nm and intensities in the range of MW/cm.sup.2 to GW/cm.sup.2 are used. Accordingly, within these limits, the amount of tissue ablated depends primarily on fluence (energy/cm.sup.2) and the same removal amount be obtained with long, low intensity pulses as with short, high intensity pulses.

We have determined that hard body tissue such as bone, tooth enamel and calcified plaque can be removed efficiently by vaporizing the soft tissue component inside the hard tissue which entrains and removes the hard component particles which are not vaporized. The boiling point of the soft component in the hard tissue is approximately 300.degree. C. A fluence of 10.sup.6 -10.sup.9 Watts/cm.sup.2 is required to vaporize the soft tissue. By comparison, the melting point of hard tissue is 1600.degree. C. To vaporize the hard component would require a fluence which is substantially greater than 10.sup.9 Watts/cm.sup.2. Thus, much less power is required to remove hard tissue using our method. Moreover, less damage is incurred to areas surrounding the surgical site by using our method of vaporizing the soft component of hard tissue without vaporizing the hard components. With our technique, plasmas are not created and less heat is transmitted to the areas surrounding the surgical site.

Also, ablation proceeds at a energy rate which is greater than the rate of thermal diffusion into the surrounding tissues. Thus, the fluence is maintained above the threshold required for tissue removal. Since the vaporization of soft tissue entrains heat away from the surgical site, the process results in a "cold cut" at the surgical site.

The determination of the requisite laser pulse parameters is extremely difficult in view of the previous lack of understanding of the nature of tissue response to laser light. The laser intensity should be great enough to vaporize the soft component in the hard tissue at a sufficiently rapid rate to entrain and remove the hard components which do not vaporize. Thus, the process requires less absorbed laser energy to remove a given amount of tissue, compared to ablation in which both tissue components are vaporized. Also, since the hot material is rapidly removed, much of the deposited heat is carried out of the tissue before it can be transferred to the adjacent tissue via thermal diffusion. The irradiance, fluence, and wavelength of a laser beam represent the fundamental controllable parameters governing the ablation process.

The effect on optical fibers involves a converse relationship. The exact path of curve 18 illustrating the probability of optical fiber survival is dependent on the power level employed. The instantaneous power in the optical fiber at any given time must be below the threshold which will cause damage. Note that the energy transmitted is directly related to the pulse duration. The damage to the optical fiber may occur when adjacent pulses overlap and breakdown thresholds are exceeded. However, optical fiber damage is rapidly reduced to a tolerable level at a pulse separation in the range of 100-200 nanoseconds. Two breakdown mechanisms predominate: self focusing and surface breakdown. Self focus damage limits peak power. Front surface breakdown restricts the pulse energy profile for a pulse energy to do ablation. Note also that the amount of energy which can be transmitted through a fiber is limited by damage of the fiber core due to electron avalanche breakdown. For shorter pulses or larger optical fiber cores, damage is caused by self focusing within the fiber core. For longer pulses or smaller optical fiber cores, damage is caused by front surface breakdown. Thus, optical fibers can only transmit high energy pulses at moderate power levels which require longer pulses.

To summarize, three requirements must be met. First, each fiber must transmit enough energy to ablate a required cross-sectional area exceeding the core diameter of the fiber. Second, peak power on each fiber must be below self focussing breakdown. Finally, the pulse energy profile on each fiber must be below the threshold for front surface breakdown. The energy required for ablation of tissue must be greater than thermal relaxation or heat dissipation at the removal site. FIG. 2 illustrates that pulse separation between 100-200 nanoseconds and 1 millisecond fulfill these requirements. By stretching the solid state laser pulse, we simply and effectively solve the mutual problems of tissue removal and optical fiber transmission. Various pulse trains and sequences of pulses with variable delays, in addition to continuous pulses can be utilized. A variety of pulse shapes can be used to increase the energy transmitted. For example, a weak first pulse with an energy below the ablation threshold can be transmitted to the surgical site, followed by a second pulse with much greater energy than the first, such that the cumulative fluence of the two pulses is sufficient to ablate tissue.

Our invention uses a pulse separation which is greater than the relaxation time of the avalanche process in the optical fiber. Thus, electron avalanche breakdown is avoided. Also, the pulse separation is less than the tissue memory, i.e., the time period during which the energy is stored. As a result, tissue is removed without damaging the optical fiber which transmits the laser pulse.

FIG. 3 shows the typical catheter environment utilized to apply the laser light at a desired body part. This, catheter is described in detail in U.S. Pat. No. 4,913,142 to Kittrell et al. which is incorporated herein by reference. As noted in Kittrell et al., spectroscopic analysis is utilized to accurately position the catheter. The laser catheter 10 contains a set of optical fibers, consisting of a central optical fiber 20a, a first ring of optic fibers represented by 20b, b', and a second ring of optical fibers 20c, c'. Note that a central lumen can also be provided in another embodiment in which a guidewire is used to position the catheter. Each optical fiber is composed of a core, a cladding with a lower index material than the core, and a protective buffer. In the preferred embodiment the-core and cladding are fused silica or glass or fluorite glass, so as to withstand high laser power. Catheter 10 is shown removing plaque 34 from within an artery 32. Laser light is applied to the optical fibers to remove overlapping nibbles 35a, b, b', and c as needed.

FIG. 4 is a block diagram for the system of the invention which utilizes spectroscopic diagnosis for removal of plaque in an artery. The pulse stretcher 229 and the pulse filler/multiplexer 231, 233 produce an output sufficient to remove tissue. The pulse stretcher optically regenerates pulses. The pulse filler/multiplexer fills the space between the pulses. Again, note that the term "extender" refers to either "stretching" pulses or "filling" pulses or both. These elements can be interchanged in this optical circuit